Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Awards and Accolades
Therapy Areas
Cardiovascular Metabolic
Bone Health
Inflammation
Oncology
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research & Development Strategy
Overview
Human & Disease Biology
Novel Targets & Modalities
Clinical Trial Optimization
AI & Data Science
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Biosimilars
Clinical Trials
Overview
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2024 Sustainability Highlights Report
Environment, Social and Governance Strategy
Healthy People
Overview
Access to Healthcare
Health Equity
Healthy Society
Overview
Diversity, Inclusion and Belonging
Human Capital Management
Community Investment and Amgen Foundation
Supplier Diversity
Healthy Planet
Overview
Environmental Sustainability
Supplier Sustainability
Healthy Amgen
Overview
Corporate Governance
Business Ethics and Compliance
Ethical Research and Development
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
Overview
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Newsroom
Partners
Investors
Careers
Amgen Worldwide
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Therapy Areas
General Medicine
Rare Disease
Inflammation
Oncology
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research & Development Strategy
Human & Disease Biology
Novel Targets & Modalities
Clinical Trial Optimization
AI in Research & Development
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2024 Sustainability Highlights Report
Corporate Sustainability Strategy
Healthy People
Access to Healthcare
Health Equity
Healthy Society
Amgen Foundation and Community Investment
Diversity, Inclusion and Belonging
Human Capital Management
Supplier Diversity
Healthy Planet
Environmental Sustainability
Supplier Sustainability
Healthy Amgen
Corporate Governance
Business Ethics and Compliance
Ethical Research and Development
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
Oncology
PATIENTS
05.16.2024
Expanding Innovation in BiTE® Technology for Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
SCIENCE & INNOVATION
04.16.2024
Navigating the Landscape of Precision Medicine in Gastric Cancer: FGFR2b Protein Overexpression as an Emerging Biomarker
PATIENTS
02.02.2024
How Amgen Is Working to Close the Care Gap This World Cancer Day
SCIENCE & INNOVATION
12.08.2023
ASH23: Advancements for Tough-to-Treat Blood Cancers
SCIENCE & INNOVATION
10.19.2023
Three Things to Look Forward to at #ESMO23
SCIENCE & INNOVATION
09.20.2023
Amgen Partners of Choice Inaugural Summit Convenes Clinical Leaders to Improve Patient Care
SCIENCE & INNOVATION
05.20.2022
Reflecting on the Power of Early Research During National Cancer Research Month
Otomatik - 18.165.183.100
CloudFlare DNS
Türk Telekom DNS
Google DNS
Open DNS
OSZAR »
